High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China
- 8 November 2012
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 58 (3), 557-563
- https://doi.org/10.1016/j.jhep.2012.10.029
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of ThiazolidinedionesCell, 2012
- Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional StudyPLOS ONE, 2011
- High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 DiabetesDiabetes Care, 2011
- Fatty liver index and mortality: The cremona study in the 15th year of follow-upHepatology, 2011
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant StateDiabetes, 2010
- Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to KetosisEndocrinology, 2009
- Adipocytokines and liver diseaseThe Esophagus, 2008
- Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelinesJournal of Gastroenterology and Hepatology, 2007
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21Cell Metabolism, 2007
- FGF-21 as a novel metabolic regulatorJCI Insight, 2005